Pfizer Financial News

Earnings season is in full swing, and next week, we've got our sights set on the healthcare sector, specifically pharmaceutical and biotechnology companies, as they get ready to reveal their quarterly results.

We don’t support this browser anymore. This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

A tornado that tore through eastern North Carolina and struck a large Pfizer pharmaceutical plant has damaged its drug storage facility but not its medicine production areas

Rutgers University in central New Jersey is equipped to make more than 1 billion prescription pills a year. Its manufacturing process is faster, cheaper and more precise than traditional methods, potentially reducing reliance on factories abroad. The technology also can be used to make drugs currently in shortage, including cancer treatments.

(Reuters) — Pfizer (NYSE:PFE) CEO Albert Bourla said on Friday that hurricane damage this week had almost completely destroyed the drugmaker's plant in Rocky Mount, North Carolina, but that production facilities do not seem to have suffered damage.

(Reuters) -The European Union's health regulator on Friday backed authorization of Pfizer (NYSE:PFE)'s vaccine for respiratory syncytial virus (RSV) for use in babies and older adults.

U.S. hospital drug supplies may be strained further after a tornado ripped open the roof of a Pfizer factory this week

A tornado has heavily damaged a large Pfizer pharmaceutical plant in North Carolina — the latest in a string of extreme weather events to plague the U.S. Floods also deluged communities in Kentucky and scorching heat smothered Phoenix and Miami yet aga...

A tornado has heavily damaged a large Pfizer pharmaceutical plant in North Carolina

Investing.com — U.S. futures edged lower Tuesday, with investors digesting a deluge of corporate earnings ahead of the release of retail sales and industrial production data.

When the RSI is above 70, it is considered overbought, indicating that the stock may be due for a correction or price pullback. Conversely, when the RSI is below 30, it is considered oversold, suggesting that the stock may be undervalued and due for a potential rebound. RSI values between 30 and 70 are considered neutral, indicating a balanced market sentiment.

Pharmaceutical company Roivant Sciences Ltd (NASDAQ:ROIV) has garnered interest from major pharmaceutical companies for its treatment of inflammatory bowel disease, estimated to be valued at over $7 billion, as reported by Bloomberg, which cited sources familiar with the matter.

Certification to the Antibiotic Manufacturing Standard will be a clear sign that manufacturers in the global antibiotic supply chain are taking necessary steps to ensure antibiotics are made responsibly, helping to minimize the risk of releasing antibiotic waste emissions into the environment.This follows the publication of the globally applicable industry standard in June 2022. The standard was facilitated by BSI for the AMR Industry Alliance, an organization made up of over 100 companies and associations from across the life-sciences industry with the shared goal of providing sustainable solutions to curb AMR.The new certification, developed by BSI to support the Standard, will offer independent third-party verification that waste streams containing antibiotic active pharmaceutical ingredient (API) and drug products are appropriately controlled during manufacturing by pharmaceutical companies.

Pacific Equity Partners is considering a tilt at New Zealand-listed engineering business Scott Technology, which is 53 per cent owned by Brazilian meat processor JBS and has Macquarie Capital running a strategic review.

Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: downgrades for Tesla and Pfizer, upgrades for Nvidia and Pinterest, and an outperform initiation for Frontier Comms.

Check out the companies making headlines in midday trading.

In this article

In this article

BEIJING — U.S. pharma giant Pfizer has signed an agreement with China to cooperate on improving the country's health coverage, according to the company.

In this article

In this article